Matt McNamara

Matt McNamaraMatt is responsible for deal flow management and evaluation, leading all investment recommendations and due diligence. He has over 25 years experience in the healthcare & medical sciences sector. After initially being a Molecular Biology Research Assistant, Matt spent 11 years in Sales & Marketing, and General Management with Merck & Co. and Johnson and Johnson Medical Pty Ltd respectively. He has served as SVP Business Development for eBioinformatics Inc and was CEO of a Life Sciences Venture Capital fund, SciCapital Pty Ltd.

Matt founded BioBridge Australia, a biotechnology commercialisation Advisory company, in 2004 and advised a number of private and public biotechnology/investment companies. Matt joined BioScience Managers in 2005 and has been Chief Investment Officer since 2008.

Matt is currently a Director of:

  • BioScience Managers Ltd
  • Avita Medical Ltd (ASX.AVH)
  • Sea Dragon Ltd (NZX.SEA)
  • SciCapital Pty Ltd
  • Rex Bionics Limited (NZ)
  • Saluda Medical Pty Ltd